These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34196723)

  • 1. Assessing Variation in State Opioid Tapering Laws: Comparing State Laws with the CDC Guideline.
    Danielson EC; Harle CA; Silverman R; Blackburn J; Menachemi N
    Pain Med; 2021 Dec; 22(12):2941-2949. PubMed ID: 34196723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State prescribing cap laws' association with opioid analgesic prescribing and opioid overdose.
    Tormohlen KN; McCourt AD; Schmid I; Stone EM; Stuart EA; Davis C; Bicket MC; McGinty EE
    Drug Alcohol Depend; 2022 Nov; 240():109626. PubMed ID: 36115221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study.
    Brighthaupt SC; Stone EM; Rutkow L; McGinty EE
    Prev Med; 2019 Sep; 126():105736. PubMed ID: 31152831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term opioid therapy tapering: Trends from 2014 to 2018 in a Midwestern State.
    Mazurenko O; Gupta S; Blackburn J; Simon K; Harle CA
    Drug Alcohol Depend; 2021 Nov; 228():109108. PubMed ID: 34688106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain.
    Goldstick JE; Guy GP; Losby JL; Baldwin G; Myers M; Bohnert ASB
    JAMA Netw Open; 2021 Jul; 4(7):e2116860. PubMed ID: 34255047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
    Guy GP; Zhang K; Bohm MK; Losby J; Lewis B; Young R; Murphy LB; Dowell D
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(26):697-704. PubMed ID: 28683056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.S. state policies on opioid prescribing during the peak of the prescription opioid crisis: Associations with opioid overdose mortality.
    Buonora MJ; Hanna DB; Zhang C; Bachhuber MA; Moir LH; Salvi PS; Cunningham CO; Starrels JL
    Int J Drug Policy; 2022 Dec; 110():103888. PubMed ID: 36270085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019.
    Davis CS; Lieberman AJ
    Addiction; 2021 Jul; 116(7):1817-1827. PubMed ID: 33245795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exemptions to state laws regulating opioid prescribing for patients with cancer-related pain: A summary.
    Bulls HW; Bell LF; Orris SR; Goodin BR; Liebschutz JM; Wozniak A; Merlin JS; Schenker Y
    Cancer; 2021 Sep; 127(17):3137-3144. PubMed ID: 34043811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
    Bachhuber MA; Saloner B; Cunningham CO; Barry CL
    JAMA Intern Med; 2014 Oct; 174(10):1668-73. PubMed ID: 25154332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes.
    McGinty EE; Tormohlen KN; Barry CL; Bicket MC; Rutkow L; Stuart EA
    Implement Sci; 2021 Jan; 16(1):2. PubMed ID: 33413454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Are Telehealth Laws Intersecting With Laws Addressing the Opioid Overdose Epidemic?
    Pepin D; Hulkower R; McCord RF
    J Public Health Manag Pract; 2020; 26(3):227-231. PubMed ID: 31348152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three Years Down the Road: The Aftermath of the CDC Guideline for Prescribing Opioids for Chronic Pain.
    Pergolizzi JV; Rosenblatt M; LeQuang JA
    Adv Ther; 2019 Jun; 36(6):1235-1240. PubMed ID: 31016474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
    Wen H; Hockenberry JM
    JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review.
    Davis CS; Lieberman AJ; Hernandez-Delgado H; Suba C
    Drug Alcohol Depend; 2019 Jan; 194():166-172. PubMed ID: 30445274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the "CDC Guideline for Prescribing Opioids for Chronic Pain" With Emergency Department Opioid Prescribing.
    Dayer LE; Breckling MN; Kling BS; Lakkad M; McDade ER; Painter JT
    J Emerg Med; 2019 Nov; 57(5):597-602. PubMed ID: 31594747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.